Agenda:
Day One: 19 January 2005
Session 1
09.00 - 09.10
Chair and Opening Welcome
Dr. Christian Zschocke, Partner, Morgan Lewis
09.10 - 09.30
Macroeconomic Demand Forecast
Keynote: Dr Richard Reid, European Equity Market Economist, Citigroup
09.30 - 09.50
The State of the Semiconductor Industry
Ralf D. Schnell, Managing Director, Infineon Ventures
09.50 - 10.40
Capital Markets
Chair: Markus Boser, Director, Technology Investment Banking, Deutsche Bank
Speakers:
Nils Rahlf, Partner, Morgan Lewis
Charlotte Crosswell, Head of Nasdaq International
Marc Zahn, Vice President, Head of Marketing & Sales, SWX Swiss Exchange
Ray J. Zimmerman, Managing Director – International, Teather & Greenwood
10.40
Coffee Break
Session 2
11.00 - 12.40
Growth Company Presentations:
Mid Caps, Small Caps and IPO Prospects
12.40
Lunch
Chair:

Session 3
14.10 - 14.30

Chair: Adi Seffer, Partner, Morgan Lewis

The Global Software Market in 2005
Heinz Steffen, Partner, fairesearch

14.30 - 14.50
Update on the Wireless Device Value Chain:
Key Battlegrounds in Semiconductors & Embedded Software

Peter Globokar, Director - Global Technology, Corporate Finance Group,
Nomura International plc
14.50 - 15.50
Panel Healthcare: Biotech & Pharma
Chair: Dimitri F. Dimitriou, Chief Executive Officer, DyoDelta Biosciences Ltd
Speakers:
Michael Forrer, Managing Director, Bioscience Managers Ltd
Matthew Speers, CEO, IC-Vec Ltd
Simon Moroney, CEO, MorphoSys AG
Paul Sylvain Larue, Managing Partner, Privateq
15.50 - 16.50
Money Managers
Chair: Karl Fickel, Partner, Lupus alpha Asset Management GmbH
Speakers:
Connie Schuemann, Senior Fondmanager, Capital Invest
Dr Marcus Manns, Portfolio Manager, Union Investment GmbH
Michael Bourne, Chief Investment Officer, Reabourne Technology Investment Management Ltd
17.00
Cocktail Reception
Day Two: 20 January 2005
Session 4
09.00 - 09.10
Opening Presentation
William van Eesteren, Director, Wilshire Associates Europe
09.10 - 09.30
Keynote: The Current State of the US Venture Capital Market: Continued Upswing? Mark G. Heesen, President, NVCA National Venture Capital Association (U.S.)
09.30 - 09.45
Keynote: VC Development in Europe vs USA.
Dr. Thomas W Kuehr, Chairman, BVK, CEO & President, T-Venture Holding
09.45 - 10.40
Panel: Investment Opportunities in 2005
Chair: Stephen Murphy, Head of Equity Private Placements Europe, Citigroup
Speakers:
Rod Perry, Global Head of Technology Investing, 3i Group plc
Dr. Hendrik Brandis, Partner, Earlybird Venture Capital
Shlomo Caine, Managing Director of Israel & Eastern Europe, Intel Capital
Helmut Schön, Managing Director, Partech International
Friedrich Bornikoel, Managing Partner, Techno Venture Management
10.40
Coffee Break
Session 5
11.10 - 12.40
Growth Company Presentations
Unlisted Companies.
12.45
Lunch
Session 6
13.45 - 14.30
Panel: Biotech Investor
Chair: Stan Yakatan, Chairman, Katan Associates
Speakers: Prof Dr Horst Domdey, CEO, Bio-M AG
Dr Jan zur Hausen, Partner, Deutsche Venture Capital
Adi Seffer, Partner, Morgan Lewis
Dr Yvonne Wegmann, Vice President, Head of Issuers & Investor Relations, SWX Swiss Exchange
Session 7
14.30 - 15.05
Coming of Age: Devices, Polymers and Drugs
Chair: Tom Geimer
Speakers:
John Gonzalez, Partner, Alice Ventures
Ralph Arnold, Managing Director, Bayer Innovation
Norbert Hultenschmidt, Bain*
Laura Howard, Morgan Stanley*
Session 8
15.05 - 15.50
Innovation from Israel
Chair: Jonathan Medved, General Partner, Israel Seed Partners
Speakers:
Dr Eli Opper, Chief Scientist, Ministry of Industry & Trade, Israel
Zeev Holtzman, Founder & CEO, Giza Venture Capital
Yoram Oron, Founder and Managing Partner, Vertex Venture Capital
Session 9
15.50 - 16.10
Russia’s Place in the Global Technology Market: Strategies for Access
Alistair Stobie, DFJ Nexus
Session 10
16.10 - 17.15
Concluding Panel: Software
Chair: Jean Schmitt, Partner, Sofinnova Partners
Speakers:
Dr Marc Breitfield, Investment/Finance Director, AdAstra Venture Consult GmbH
Michael Wand, Director, Carlyle Group
Paul Jozefak, Investment Director, SAP Ventures
Dr Uwe Albrecht, Head of Corporate Fund, Siemens Venture Capital GmbH
Dr Berthold v. Freyberg, Partner, Target Partners
17.15
Close of Conference
 

To download a pdf version of this agenda click here.

*tbc

Back to top